TY  - RPRT
TI  - Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.
AU  - C A Farquharson
AU  - A D Struthers
PY  - 2000
DO  - 10.1161/01.cir.101.6.594
UR  - https://pubmed.ncbi.nlm.nih.gov/10673249/
ID  - 10673249
ER  -